Adagio Medical Holdings, Inc. (ADGM) — Financial statements
Income statement, balance sheet, and cash flow for Adagio Medical Holdings, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 0.00↓100.0% | 0.27↓10.3% | 0.30↑58.7% | 0.19↓30.0% | 0.27 | |
| Cost of Revenue | 2↓14.6% | 2↑48.3% | 1↑49.3% | 0.88↓24.4% | 1 | |
| Gross Profit | -2↑0.8% | -2↓65.8% | -1↓46.6% | -0.69↑22.7% | -0.89 | |
| Operating Expenses | ||||||
| R&D Expenses | 11↑129.6% | 5↓69.9% | 15↓13.8% | 18↑16.3% | 15 | |
| General & Administrative Expenses | 0.00 | 0.00↓100.0% | 5 | 0.00 | 0.00 | |
| Selling & Marketing Expenses | 0.00 | 0.00↓100.0% | 7 | 0.00 | 0.00 | |
| SG&A Expenses | 10↑37.6% | 7↓39.5% | 12↑114.8% | 5↑22.0% | 4 | |
| Other Expenses | 0.00↓100.0% | 49 | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | 20↓66.7% | 61↑125.8% | 27↑16.0% | 23↑17.6% | 20 | |
| Total Costs & Expenses | 22↓65.1% | 63↑122.2% | 28↑17.2% | 24↑15.2% | 21 | |
| Operating Results | ||||||
| Operating Income | -22↑65.0% | -62↓123.6% | -28↓16.8% | -24↓15.8% | -21 | |
| Depreciation & Amortization | 0.97↑112.7% | -8↓1530.8% | 0.53↑7.5% | 0.50↑47.3% | 0.34 | |
| EBITDA | -21↑66.5% | -62↓127.9% | -27↓19.0% | -23↓17.5% | -20 | |
| EBIT | -22↑60.1% | -55↓96.4% | -28↓18.7% | -24↓18.0% | -20 | |
| Interest & Other Income | ||||||
| Net Interest Income | -2↓259.3% | 2↑192.1% | -2↓1589.8% | -0.10↓3366.7% | 0.00 | |
| Interest Income | 0.48↑12.8% | 0.42↑14000.0% | 0.00↓92.3% | 0.04↑1200.0% | 0.00 | |
| Interest Expense | 3↑363.7% | -1↓166.4% | 2↑1110.9% | 0.14 | 0.00 | |
| Non-Operating Income | 0.00↑100.0% | -8 | 0.00↑100.0% | -0.38↑46.7% | -0.71 | |
| Other Income / Expenses | -3↓136.6% | 9↑185.4% | -10↓4351.7% | 0.24↓66.1% | 0.71 | |
| Income Before Tax | -25↑53.3% | -54↓40.9% | -38↓61.1% | -24↓18.7% | -20 | |
| Income Tax Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -25↑53.3% | -54↓40.9% | -38↓61.1% | -24↓18.7% | -20 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -25↑53.3% | -54↓40.9% | -38↓61.1% | -24↓18.7% | -20 | |
| Bottom-Line Net Income | -25↑53.3% | -54↓2420.1% | -2↑91.0% | -24↓18.7% | -20 | |
| EPS (Basic) | -1.51↑57.3% | -3.54↑27.2% | -4.86↓8841.0% | 0.06↑116.4% | -0.34 | |
| EPS (Diluted) | -1.51↑57.3% | -3.54↑27.2% | -4.86↓8841.0% | 0.06↑116.4% | -0.34 | |
| Weighted Average Shares | 17↑9.1% | 15↑93.5% | 8↓59.1% | 19↑0.0% | 19 | |
| Weighted Average Diluted Shares | 17↑9.1% | 15↑93.5% | 8↓59.1% | 19↑0.0% | 19 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.